Russia expands miner regulation, requiring ASIC miners to report network addresses
According to ChainCatcher, as reported by Bits Media, the Russian government has expanded the information miners and mining infrastructure operators are required to submit to the tax authorities. Under the new regulations, the national registry for miners and operators must include network address data for devices used in cryptocurrency mining (ASIC mining machines). The Russian Ministry of Finance stated that this move aims to streamline the supervision of digital asset transactions and the investigation of violations. Moreover, grid operators will be able to more accurately monitor infrastructure loads in regions with high concentrations of mining capacity.
According to legal provisions, government agencies, courts, the Bank of Russia, and power grid operators all have access to information in the miner registry. The Federal Tax Service is responsible for maintaining the registry of miners and mining infrastructure operators. Under current law, miners and infrastructure operators (such as mining pools) are required to submit and regularly update the following information: for mining equipment, they must provide details on the manufacturer, model, serial number, algorithm, computing power, power consumption, and operating mode. Regarding mining activities: they must report the amount and type of cryptocurrency mined, the mining pool, and links to online statistical data.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Bark names CFO Anya Hamill principal accounting officer after Brian Dostie resignation
Bark named CFO Anya Hamill as principal accounting officer effective Oct. 9, 2026. Principal accounting officer Brian Dostie resigned effective Oct. 23, 2026. He stopped serving in the role on Oct. 9. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bark Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001628280-26-065536), on October 09, 2026, and is solely responsible for the information contained therein.
Microsoft launches high-speed decision AI model, 35 times faster than GPT-6 Sol
Microsoft has launched a dedicated AI model, Microsoft-Decision-1, designed specifically for structured decision-making tasks. This model can select the optimal solution from preset options and assign probability scores, supporting scenarios such as routing distribution, content classification, and task prioritization. Internal testing shows that its speed is 35 times faster than GPT-6 Sol, with an input cost of only $0.042 per million tokens and free output.

Singapore Dollar: MAS tightening but gains constrained – OCBC
BUZZ-Moderna stock surges after inclusion in Nasdaq 100 index; Bank of America raises target price
On October 9, Moderna (MRNA.O) shares rose by about 12% to $220 on Friday, after reaching their highest point since January 2022, as the company was added to the Nasdaq 100 Index (.NDX). Bank of America raised its price target for the stock from $170 to $200. On Thursday, the stock closed at $197. Bank of America analysts maintained a neutral rating and noted that the price target was raised due to a slight reduction in expectations for U.S. COVID-related revenues, offset by anticipated growth in influenza sales by 2027. This also factored in an increase in the expected price for intismeran, as well as projected sales growth for the drug in the coming years; intismeran is a cancer vaccine co-developed with Merck (MRK.N). However, they pointed out that much of intismeran's value has already been reflected in the share price ahead of the European Society for Medical Oncology (ESMO) conference and upcoming data releases. Since the third-quarter earnings report will only be announced after the presentation at the ESMO conference on October 24, Bank of America noted that the significance of the Q3 results is relatively low. Nevertheless, BofA still expects the company to achieve its guidance of up to 10% revenue growth for 2026, with year-end cash holdings reaching $4.7 billion to $5.2 billion. The bank also stated its forecast for third-quarter preventive vaccine revenue is $812 million, below market consensus, and its total revenue estimate of $848 million is likewise below consensus. Since August 18, Moderna's stock price has been on a strong uptrend, following encouraging late-stage clinical data on intismeran, which encouraged investors to buy the stock. Moderna was included in the Nasdaq 100 Index (link), replacing Warner Bros. Discovery, which is set to merge with Paramount Global. Year-to-date, Moderna shares are up about 650%, marking the largest annual gain in its history, making it the top performer in the S&P 500 Index (.SPX) year-to-date. In contrast, the S&P 500 Healthcare Index (.SPXHC) is up only 10.3% so far in 2026. (For the convenience of non-English speakers, Reuters provides automated translation of its reports into several other languages. As automated translation may contain errors or lack required context, Reuters does not guarantee the accuracy of automated translated texts, and these are provided solely for the reader's convenience. Reuters assumes no responsibility for any damage or losses caused by the use of automated translation functionality.)
